IEICE, et al, IEICE ESS Fundam Rev (2020), cited as Ref 51 in DOI:10.1007/s11886-020-01292-3 (Q10560)

From Wikibase.slis.ua.edu
Revision as of 21:15, 23 June 2020 by Admin (talk | contribs) (‎Added link to [sliswiki]: IEICE, et al, IEICE ESS Fundam Rev (2020), cited as Ref 51 in DOI:10.1007/s11886-020-01292-3, #quickstatements; #temporary_batch_1592946843269)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Cited in: "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response" Research article published in Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32.
Language Label Description Also known as
English
IEICE, et al, IEICE ESS Fundam Rev (2020), cited as Ref 51 in DOI:10.1007/s11886-020-01292-3
Cited in: "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response" Research article published in Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32.

    Statements

    occurs in
    Q10356 (Deleted Item)
    0 references
    title
    Overview of planned or ongoing studies of drugs for the treatment of COVID-19 (English)
    0 references
    First Author string
    IEICE
    0 references
    Publication Date
    2020
    0 references
    Published In Name String
    IEICE ESS Fundam Rev
    0 references
    Page(s)
    177-
    0 references
    Issue
    3
    0 references
    Volume
    13
    0 references
     

    Sitelinks

    Retrieved from "http://wikibase.slis.ua.edu/w/index.php?title=Item:Q10560&oldid=225008"